ArticleClinical and experimental pediatrics2025
Bridging the gap: autism spectrum disorder in children in the United States and worldwide: a narrative review.
Article in Clinical and experimental pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Amplifying the Voices of Parents From Underserved Communities in Digital Health for Children With Medical Complexity: Interview Study Among Parents.JMIR pediatrics and parenting · 2026Article
- Emerging information technologies across the autism service and prevention continuum: a narrative review of screening, diagnosis, intervention, and health equity.Frontiers in public health · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by difficulty with communication and social interactions as well as restricted or repetitive behaviors. Over the last few decades, the prevalence of ASD has increased globally, with major differences in reporting, diagnosis, and interventions between developed and developing countries. The United States (U.S.) has seen a sharp rise in diagnosed ASD cases, with a current prevalence of approximately 1 in 31 children, due to improved awareness, early screening programs, and timely intervention. The U.S. healthcare system supports early intervention services through policies such as the Individuals with Disabilities Education Act and insurance mandates for ASD coverage. However, countries in Latin America, Africa, and Asia face challenges in ASD care, including limited access, stigma, underdiagnosis, and lack of resources. The World Health Organization Caregiver Skills Training, a global initiative, and the involvement of nongovernmental organizations are gradually bridging this gap. An interprofessional approach highlighting cross-cultural research, training providers, screening tools, referral options, policy implementation, and community-based care on a global scale will help reduce disparities in ASD care among countries. Making ASD care a global public health priority could help ensure developmental and mental healthcare equity. This study compares ASD care in the U.S. to that worldwide, highlighting the importance of global collaboration for early detection, service availability, and research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.